Fennec Pharmaceuticals Inc. (FENC) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$12,368
Total Return
23.68%
CAGR
4.34%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.77% |
| Median | +0.84% |
| Best | +58.63% |
| Worst | -59.01% |
| % of Windows Positive | 52.8% |
1-Year (252 Trading Days)
| Average | +13.57% |
| Median | +7.85% |
| Best | +147.30% |
| Worst | -53.99% |
| % of Windows Positive | 57.2% |
3-Year (756 Trading Days)
| Average | +1.46% |
| Median | -2.78% |
| Best | +59.32% |
| Worst | -57.66% |
| % of Windows Positive | 46.5% |
Risk Metrics
| Maximum Drawdown | -65.63% |
| Average Drawdown | -29.34% |
| Drawdown Duration | 608 Trading Days (Unrecovered) |
| Sortino Ratio | 0.54 |
| Calmar Ratio | 0.07 |
| CVaR (5%) | -8.09% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +18.70% (+50.17% ann.) | +$1870.13 | $0.00 | $0.00 | $0.00 |
| 2025 | +21.84% | +$2183.54 | $0.00 | $0.00 | $0.00 |
| 2024 | -43.67% | $4367.20 | $0.00 | $0.00 | $0.00 |
| 2023 | +16.87% | +$1687.50 | $0.00 | $0.00 | $0.00 |
| 2022 | +118.18% | +$11818.16 | $0.00 | $0.00 | $0.00 |
| 2021 | -40.94% | $4093.95 | $0.00 | $0.00 | $0.00 |
| 2020 | +14.79% | +$1479.20 | $0.00 | $0.00 | $0.00 |
| 2019 | +1.72% | +$172.40 | $0.00 | $0.00 | $0.00 |
| 2018 | -36.33% | $3632.73 | $0.00 | $0.00 | $0.00 |
| 2017 partial | -16.50% (-46.60% ann.) | $1650.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | September 15, 2017 – February 19, 2020 | -33.21% | -15.31% | $3320.83 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -35.06% | -99.28% | $3506.18 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +31.98% | +56.28% | +$3197.87 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -40.62% | -39.01% | $4062.11 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +88.61% | +96.15% | +$8861.07 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -35.70% | -21.20% | $3569.69 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +75.10% | +38.88% | +$7509.59 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.